NS-HGlio

JSON twin: https://www.healthaidb.com/software/ns-hglio.json

Company Name

Neosoma

Product URL

https://neosoma.com/ns-hglio

Company URL

https://neosoma.com

Categories

• clinical Care
• diagnostic Support
• imaging Software
• ai Clinical Documentation Integrity
• clinical Decision Support
• radiology
• oncology Care
• medical Device
• medical Device Software
• clinical Assessment Tools
• Clinical
• Diagnostic
• Medical Imaging
• Artificial Intelligence
• Oncology
• Neuro-oncology
• Software-as-a-medical-device (samd)
• Tumor Assessment

Summary

NS-HGlio is an AI-driven software developed by Neosoma for precise segmentation and volumetric measurement of high-grade gliomas in MRI scans, enhancing tumor assessment accuracy and aiding in treatment decisions.

Description

NS-HGlio is an FDA-cleared software-as-a-medical-device (SaMD) that utilizes deep learning algorithms to semi-automatically segment and measure high-grade gliomas in MRI images. It provides volumetric data and visual overlays to assist clinicians in monitoring tumor progression and evaluating treatment responses. The software has demonstrated high accuracy, with a mean Dice Similarity Coefficient of 0.88 for preoperative scans and 0.80 for postoperative scans, outperforming expert averages. It is intended as an adjunct tool for qualified clinical personnel and is not designed for primary diagnosis. NS-HGlio integrates with clinical Picture Archiving and Communication Systems (PACS) and has been validated in multiple clinical settings, including active clinical trials at UCLA's Brain Tumor Imaging Lab. The technology was detailed in a publication in Neuro-Oncology Advances, highlighting its development and performance. Neosoma, founded in 2019, is headquartered in Groton, Massachusetts, and focuses on advancing brain cancer care through AI-driven tumor analytics.

Api Available

yes

Certifications

• FDA 510(k)
• CE/MDR
• ONC
• ISO

Company Founding

2019

Company Offices

• United States

Compliance

• HIPAA
• GDPR
• HITECH
• SOC 2
• ISO 27001

Customers

Data Residency

US/EU regions

Data Standards

• FHIR
• HL7 v2
• DICOM
• SNOMED
• ICD-10

Deployment Model

• SaaS

Features

• Confidential smart contract execution
• Encrypted data management
• Scalable DeFi applications
• Intel SGX integration
• Zero-knowledge proofs
• Cross-chain interoperability
• Multi-signature support
• Service registry
• Template generation
• Dependency injection
• Comprehensive testing
• CI/CD pipelines
• Docker support
• Production deployment tools
• Enterprise-grade security
• Modular architecture
• High availability
• Horizontal scaling
• End-to-end encryption
• Service mesh

Id

SW0405

Integration Partners

Integrations

• Neo N3
• Intel SGX
• ARM TrustZone
• Neo Blockchain
• Cloud providers

Languages Supported

• English
• Spanish
• French
• German
• Italian
• Portuguese
• Dutch
• Swedish
• Norwegian
• Danish
• Finnish
• Russian
• Chinese
• Japanese
• Korean
• Arabic
• Hindi
• Bengali
• Punjabi
• Gujarati

Last Updated

2025-10-11

License

Commercial

Market Segment

• Enterprise
• Clinical Research
• Healthcare Providers
• Medical Institutions
• Clinical Trials

Optional Modules

• Privacy computing
• Blockchain bridge
• Compliance suite
• Authentication
• Cross-chain
• Testing suite

Os Platforms

• Web

Pricing Details

Contact vendor for pricing information.

Pricing Model

Subscription

Privacy Features

• BAA available
• Consent management
• Anonymization
• Data minimization

Product Code

SW0405

Product Name

NS-HGlio

Ratings

Regions Available

• United States
• Europe
• Canada
• Australia
• Japan
• South Korea
• China
• India
• Brazil
• Mexico
• South Africa
• United Kingdom
• Germany
• France
• Italy
• Spain
• Netherlands
• Sweden
• Norway
• Denmark

Related Urls

• https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices

Release Year

Security Features

• Encryption
• RBAC
• SSO/SAML
• Audit logs
• 2FA
• DLP

Specialties

• Neuro-oncology
• Radiology
• Oncology
• Medical Imaging
• Clinical Research
• Tumor Assessment
• Brain Cancer
• Glioma
• High-grade Glioma
• Mri Imaging

Support Channels

System Requirements

Target Users

• Clinicians
• Neuroradiologists
• Oncologists
• Neuro-Oncologists
• Medical Imaging Specialists
• Clinical Researchers
• Healthcare Professionals

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "NS-HGlio",
  "company_name": "Neosoma",
  "product_url": "https://neosoma.com/ns-hglio",
  "company_url": "https://neosoma.com",
  "related_urls": [
    "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
  ],
  "product_code": "SW0405",
  "summary": "NS-HGlio is an AI-driven software developed by Neosoma for precise segmentation and volumetric measurement of high-grade gliomas in MRI scans, enhancing tumor assessment accuracy and aiding in treatment decisions.",
  "description": "NS-HGlio is an FDA-cleared software-as-a-medical-device (SaMD) that utilizes deep learning algorithms to semi-automatically segment and measure high-grade gliomas in MRI images. It provides volumetric data and visual overlays to assist clinicians in monitoring tumor progression and evaluating treatment responses. The software has demonstrated high accuracy, with a mean Dice Similarity Coefficient of 0.88 for preoperative scans and 0.80 for postoperative scans, outperforming expert averages. It is intended as an adjunct tool for qualified clinical personnel and is not designed for primary diagnosis. NS-HGlio integrates with clinical Picture Archiving and Communication Systems (PACS) and has been validated in multiple clinical settings, including active clinical trials at UCLA's Brain Tumor Imaging Lab. The technology was detailed in a publication in Neuro-Oncology Advances, highlighting its development and performance. Neosoma, founded in 2019, is headquartered in Groton, Massachusetts, and focuses on advancing brain cancer care through AI-driven tumor analytics.",
  "categories": [
    "clinical Care",
    "diagnostic Support",
    "imaging Software",
    "ai Clinical Documentation Integrity",
    "clinical Decision Support",
    "radiology",
    "oncology Care",
    "medical Device",
    "medical Device Software",
    "clinical Assessment Tools",
    "Clinical",
    "Diagnostic",
    "Medical Imaging",
    "Artificial Intelligence",
    "Radiology",
    "Oncology",
    "Neuro-oncology",
    "Medical Device",
    "Software-as-a-medical-device (samd)",
    "Tumor Assessment"
  ],
  "market_segment": [
    "Enterprise",
    "Clinical Research",
    "Healthcare Providers",
    "Medical Institutions",
    "Clinical Trials"
  ],
  "target_users": [
    "Clinicians",
    "Neuroradiologists",
    "Oncologists",
    "Neuro-Oncologists",
    "Medical Imaging Specialists",
    "Clinical Researchers",
    "Healthcare Professionals"
  ],
  "specialties": [
    "Neuro-oncology",
    "Radiology",
    "Oncology",
    "Medical Imaging",
    "Clinical Research",
    "Tumor Assessment",
    "Brain Cancer",
    "Glioma",
    "High-grade Glioma",
    "Mri Imaging"
  ],
  "regions_available": [
    "United States",
    "Europe",
    "Canada",
    "Australia",
    "Japan",
    "South Korea",
    "China",
    "India",
    "Brazil",
    "Mexico",
    "South Africa",
    "United Kingdom",
    "Germany",
    "France",
    "Italy",
    "Spain",
    "Netherlands",
    "Sweden",
    "Norway",
    "Denmark"
  ],
  "languages_supported": [
    "English",
    "Spanish",
    "French",
    "German",
    "Italian",
    "Portuguese",
    "Dutch",
    "Swedish",
    "Norwegian",
    "Danish",
    "Finnish",
    "Russian",
    "Chinese",
    "Japanese",
    "Korean",
    "Arabic",
    "Hindi",
    "Bengali",
    "Punjabi",
    "Gujarati"
  ],
  "pricing_model": "Subscription",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "Commercial",
  "company_offices": [
    "United States"
  ],
  "company_founding": "2019",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "Confidential smart contract execution",
    "Encrypted data management",
    "Scalable DeFi applications",
    "Intel SGX integration",
    "Zero-knowledge proofs",
    "Cross-chain interoperability",
    "Multi-signature support",
    "Service registry",
    "Template generation",
    "Dependency injection",
    "Comprehensive testing",
    "CI/CD pipelines",
    "Docker support",
    "Production deployment tools",
    "Enterprise-grade security",
    "Modular architecture",
    "High availability",
    "Horizontal scaling",
    "End-to-end encryption",
    "Service mesh"
  ],
  "optional_modules": [
    "Privacy computing",
    "Blockchain bridge",
    "Compliance suite",
    "Authentication",
    "Cross-chain",
    "Testing suite"
  ],
  "integrations": [
    "Neo N3",
    "Intel SGX",
    "ARM TrustZone",
    "Neo Blockchain",
    "Cloud providers"
  ],
  "data_standards": [
    "FHIR",
    "HL7 v2",
    "DICOM",
    "SNOMED",
    "ICD-10"
  ],
  "api_available": "yes",
  "system_requirements": "",
  "compliance": [
    "HIPAA",
    "GDPR",
    "HITECH",
    "SOC 2",
    "ISO 27001"
  ],
  "certifications": [
    "FDA 510(k)",
    "CE/MDR",
    "ONC",
    "ISO"
  ],
  "security_features": [
    "Encryption",
    "RBAC",
    "SSO/SAML",
    "Audit logs",
    "2FA",
    "DLP"
  ],
  "privacy_features": [
    "BAA available",
    "Consent management",
    "Anonymization",
    "Data minimization"
  ],
  "data_residency": "US/EU regions",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0405",
  "slug": "ns-hglio",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/ns-hglio.json"
  }
}